Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel L-arginine catalyzed Henry reaction in water. High yield, eco-friendly, scalable for pharmaceutical intermediates manufacturing.
Patent CN111892559B details a high-yield asymmetric epoxidation of chalcones using chiral TADDOL ligands and rare earth metal amides, offering significant cost reduction in chiral epoxide manufacturing.
Patent CN114853609B details Pd-catalyzed allyl diether synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high purity and scalability.
Patent CN103497227B reveals a mild epoxidation method for tulathromycin intermediates, offering significant supply chain stability and cost reduction benefits.
Patent CN115260085A reveals a safer Pd-catalyzed route for 3-nitro-9-ethylcarbazole. Enhance supply chain reliability and reduce manufacturing costs significantly.
Novel preparation method offers high yield and low waste for agrochemical and pharmaceutical intermediates supply chain optimization.
Patent CN115611695B reveals metal-free synthesis for substituted naphthalene derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115611695B reveals metal-free naphthalene synthesis. Offers cost reduction and supply reliability for pharma intermediates manufacturing.
Patent CN110590621A reveals a copper-catalyzed route for sulfone derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111118529B reveals a diaphragm-free electrochemical method for synthesizing high-purity alpha,alpha-dibromoketones, offering significant cost reduction in fine chemical manufacturing.
Patent CN106831551B reveals ionic liquid method for sulfonylpyridines. High yield over ninety percent. Reduced waste. Reliable supply chain for agrochemical and pharma intermediates.
Patent CN113999201B details chiral asymmetric synthesis for high-purity nicotine. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN111393333B details a green aqueous silver-catalyzed dearomatization method. This breakthrough offers high regioselectivity and scalable production for pharmaceutical intermediates.
Patent CN111138392B reveals a mild 90-120°C route to 2,5-Furandicarboxylic Acid from furfural using O2 and CO2, offering significant cost reduction in polymer additive manufacturing.
Patent CN107540616B details a novel 4-step route to chiral pyrazolamines with 94% ee, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical manufacturing.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Patent CN1290692A reveals a novel zinc-catalyzed method for carbamate synthesis, offering superior purity and speed for reliable API intermediate supply chains.
Patent CN115074760B reveals green electrochemical route. Reduces oxidant waste, enhances supply chain reliability for pharma intermediates manufacturing globally.
Patent CN111018795A reveals a high-selectivity base-catalyzed route for quinoxaline-3-one, offering cost reduction in pharmaceutical intermediates manufacturing and scalable production.
Patent CN101830821B reveals a high-yield bisulfate-catalyzed route for N-alkoxyoxalyl alanine ester, offering significant cost reduction and scalable manufacturing for vitamin B6 intermediates.